dihexa human clinical trials 2026 bpc 157 bpc-157 trial kpv tb500 human status SCOPE 2026, Simplified Patient Recruitment Management, AI Powered Clinical Trial Finders Regeneration or Risk? A Narrative – Eleven clinical trials that will

Retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors, not yet approved by the MHRA or EMA for use in the UK

Control of cell state transitions

The goal is simple: make access to medically guided treatment more efficient, while maintaining appropriate clinical oversight at every step

Improved Cognitive Function B12 supports brain health and cognitive performance through several mechanisms: Maintains myelin sheaths that protect and insulate nerves Supports neurotransmitter production and regulation Enhances blood flow and oxygen delivery to the brain Reduces homocysteine levels (elevated levels are linked to cognitive decline) Many clients report better concentration, improved memory, and greater mental clarity after beginning B12 therapy

The appetite suppression cagrilintide produces makes eating feel less urgent, which can lead to inadequate protein intake if not consciously addressed

Read more about what this means here.